Replies to post #30135 on DNAprint Genomics (DNAG)

[Blue Juggernaut]

Stakddek,

Well written. You are turning into the Steven King of the board... quantity and quality.

I'm with you. I have paid my price to be admitted to the shaw and don't want to miss a moment of the saga. I have a relatively low cost base. I am invested in this company. I have hope.

Big Blue

[eb0783]

Stakddek: another very good post. I wanted to comment on this part:

"Trace and our new employees are world reknown for past works. These minds will be applied to some of the same problems Doctor Frudakis is working on. Maybe even have stumped him."

Here is my interpretation of Tony's words and feelings on Trace from the shareholders's meeting (as I remember). I think he feels they are just about his equal. He commented on a number of things that he and they had in common. The differentiator that has DNAG buying Trace rather than trace being ahead (meaning as a more successful company than DNAG) is about the financing that we all claim to lament. His terminology of a VC is that kind that invests, owns control of, and stays with you. He says he has tried to avoid that kind (thus the financial deals that result in quickly reselling DNAG stock and NOT maintaining a sizeable ownership). He claims that Trace was at the mercy of their VC (who controlled them) as was Biofrontera (the reason that the first Biofrontera deal fell through). This is all my interpretation and not word-for-word from him.

Paul